Across the United States, millions of people are living with chronic symptoms that never receive a real explanation. Digestive issues, fatigue, nutrient deficiencies, skin problems, autoimmune-like flare-ups, neurological changes, respiratory conditions, and the all too common “mystery illness” label often leave patients searching for answers that never come. For countless Americans, the underlying cause is never identified, not because it is not real, but because our medical and environmental systems were never designed to detect parasitic infections in everyday people.
This silent epidemic continues to grow while slipping through the cracks of outdated testing, narrow diagnostic assumptions, and a healthcare system that rarely considers parasites unless international travel is involved. Many parasites shed intermittently, meaning standard stool tests often fail to detect them. Most laboratories also screen for only a small fraction of the thousands of known parasitic organisms. Meanwhile, the symptoms of parasitic illness often resemble conditions such as irritable bowel syndrome, Crohn’s disease, allergies, asthma, chronic fatigue, skin disorders, and nutrient deficiencies, leading to years of misdiagnosis.
Medical education devotes relatively little time to parasitology, leaving many healthcare providers with limited training in recognizing these infections. If parasites are not considered as part of the diagnostic process, they are unlikely to be identified. Even the Centers for Disease Control and Prevention acknowledges that reported cases of parasitic diseases in the United States are likely an underestimate of the true number because underrecognition leads to underreporting, and underreporting reduces the urgency for further research and public health action.
Global health experts and the CDC confirm that parasitic infections continue to occur throughout the United States and, in some cases, affect millions of people. These infections can result in serious complications, including seizures, blindness, heart failure, infertility, and even death. Despite these risks, they frequently go undetected because of nonspecific symptoms, limited testing options, and outdated diagnostic practices. The situation became even more challenging in 2021 when the CDC suspended most of its parasitic diagnostic testing services, a decision many experts said negatively affected patient care by delaying or preventing proper evaluation. For many Americans, this reflects an ongoing reality: they are sick, but the healthcare system is often not equipped to determine whether parasites may be the cause.
The issue extends beyond human health and into agriculture, where farmers are increasingly reporting parasites that are resistant to commonly used deworming medications. Research conducted by the University of Missouri found that parasites affecting cattle are becoming more resistant to treatment, particularly to macrocyclic lactones, one of the most widely used classes of deworming drugs. Producers report resistant parasites spreading through herds, declining productivity, rising veterinary expenses, and fewer effective treatment options. Livestock specialists warn that decades of widespread dewormer use have accelerated resistance, forcing producers to rethink parasite management strategies. This agricultural trend has broader implications because resistant parasites and their genetic traits can spread through soil, water, wildlife, and other shared environmental pathways. Historically, resistance patterns first observed in animals have often served as an early warning of resistance that later emerges in human medicine.
When parasitic infections remain undetected, they can mimic or contribute to conditions such as irritable bowel syndrome, inflammatory bowel disease, increased intestinal permeability, chronic inflammation, asthma-like respiratory symptoms, eczema, nutrient deficiencies, and autoimmune-like disorders. Without identifying the underlying cause, many patients spend years cycling through medications, specialists, and conflicting diagnoses while their symptoms persist.
This issue is neither rare nor hypothetical. It represents a significant blind spot in American public health. Addressing it will require updated diagnostic technologies, broader clinical awareness, expanded education in parasitology, and meaningful investment in research focused on domestically acquired parasitic infections. Americans deserve answers instead of dismissal, and it is time to bring this overlooked public health challenge into the national conversation.